FZD9 and non-small cell lung carcinoma: E-cadherin is a well-known marker of epithelial differentiation [21], [22] and has previously been shown to be an important downstream target for both Wnt7a/Fzd9 signaling and PPARγ expression in NSCLC [6], [23].